These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

476 related items for PubMed ID: 33753543

  • 1. Thrombosis Risk in Transgender Adolescents Receiving Gender-Affirming Hormone Therapy.
    Mullins ES, Geer R, Metcalf M, Piccola J, Lane A, Conard LAE, Mullins TLK.
    Pediatrics; 2021 Apr; 147(4):. PubMed ID: 33753543
    [Abstract] [Full Text] [Related]

  • 2. Venous thromboembolism in transgender and gender non-binary youth is rare and occurs in the setting of secondary risk factors: A retrospective cohort study.
    Baskaran C, Roberts SA, Barrera E, Pilcher S, Kumar R.
    Pediatr Blood Cancer; 2024 Nov; 71(11):e31284. PubMed ID: 39187964
    [Abstract] [Full Text] [Related]

  • 3. Longitudinal Changes in Liver Enzyme Levels Among Transgender People Receiving Gender Affirming Hormone Therapy.
    Hashemi L, Zhang Q, Getahun D, Jasuja GK, McCracken C, Pisegna J, Roblin D, Silverberg MJ, Tangpricha V, Vupputuri S, Goodman M.
    J Sex Med; 2021 Sep; 18(9):1662-1675. PubMed ID: 34366264
    [Abstract] [Full Text] [Related]

  • 4. Hormone Concentrations in Transgender Women Who Self-Prescribe Gender Affirming Hormone Therapy: A Retrospective Study.
    Salakphet T, Mattawanon N, Manojai N, Muangmool T, Tangpricha V.
    J Sex Med; 2022 May; 19(5):864-871. PubMed ID: 35379590
    [Abstract] [Full Text] [Related]

  • 5. Prevalence of and factors associated with the use of gender-affirming hormonal therapy outside the reference regimen among transgender people in a community-led clinic in Metro Manila, Philippines: a retrospective cross-sectional study.
    Eustaquio PC, Dela Cruz JDM, Araña Y, Rosos B, Rosadiño JDT, Pagtakhan RG, Regencia ZJG, Baja ES.
    BMJ Open; 2023 Sep 05; 13(9):e072252. PubMed ID: 37669846
    [Abstract] [Full Text] [Related]

  • 6. Adherence to Gender Affirming Hormone Therapy in Transgender Adolescents and Adults: A Retrospective Cohort Study.
    Gupta P, Patterson BC, Chu L, Gold S, Amos S, Yeung H, Goodman M, Tangpricha V.
    J Clin Endocrinol Metab; 2023 Oct 18; 108(11):e1236-e1244. PubMed ID: 37246711
    [Abstract] [Full Text] [Related]

  • 7. Breakthrough Bleeding in Transgender and Gender Diverse Adolescents and Young Adults on Long-Term Testosterone.
    Grimstad F, Kremen J, Shim J, Charlton BM, Boskey ER.
    J Pediatr Adolesc Gynecol; 2021 Oct 18; 34(5):706-716. PubMed ID: 33910088
    [Abstract] [Full Text] [Related]

  • 8. Association of Gender-Affirming Hormone Therapy With Depression, Thoughts of Suicide, and Attempted Suicide Among Transgender and Nonbinary Youth.
    Green AE, DeChants JP, Price MN, Davis CK.
    J Adolesc Health; 2022 Apr 18; 70(4):643-649. PubMed ID: 34920935
    [Abstract] [Full Text] [Related]

  • 9. Expanding upon the relationship between gender-affirming hormone therapy, neural connectivity, mental health, and body image dissatisfaction.
    Grannis C, Mattson WI, Leibowitz SF, Nahata L, Chen D, Strang JF, Thobe H, Indyk JA, Nelson EE.
    Psychoneuroendocrinology; 2023 Oct 18; 156():106319. PubMed ID: 37331310
    [Abstract] [Full Text] [Related]

  • 10. Which U.S. States' Medicaid Programs Provide Coverage for Gender-Affirming Hormone Therapy and Gender-Affirming Genital Surgery for Transgender Patients?: A State-by-State Review, and a Study Detailing the Patient Experience to Confirm Coverage of Services.
    Zaliznyak M, Jung EE, Bresee C, Garcia MM.
    J Sex Med; 2021 Feb 18; 18(2):410-422. PubMed ID: 33422448
    [Abstract] [Full Text] [Related]

  • 11. Effects of gender affirming hormone treatment in transgender individuals - a retrospective cohort study.
    Muir CA, Guttman-Jones M, Man EJ.
    Endocrine; 2024 Jul 18; 85(1):370-379. PubMed ID: 38386168
    [Abstract] [Full Text] [Related]

  • 12. The Effect of Gender-Affirming Hormone Therapy on the Risk of Subclinical Atherosclerosis in the Transgender Population: A Systematic Review.
    Moreira Allgayer RMC, Borba GDS, Moraes RS, Ramos RB, Spritzer PM.
    Endocr Pract; 2023 Jun 18; 29(6):498-507. PubMed ID: 36603652
    [Abstract] [Full Text] [Related]

  • 13. Short-Term Effects of Gender-Affirming Hormone Therapy on Dysphoria and Quality of Life in Transgender Individuals: A Prospective Controlled Study.
    Foster Skewis L, Bretherton I, Leemaqz SY, Zajac JD, Cheung AS.
    Front Endocrinol (Lausanne); 2021 Jun 18; 12():717766. PubMed ID: 34394009
    [Abstract] [Full Text] [Related]

  • 14. Gender-affirming hormone therapy and the risk of sex hormone-dependent tumours in transgender individuals-A systematic review.
    McFarlane T, Zajac JD, Cheung AS.
    Clin Endocrinol (Oxf); 2018 Dec 18; 89(6):700-711. PubMed ID: 30107028
    [Abstract] [Full Text] [Related]

  • 15. Venous Thromboembolism and Estrogen-Containing Gender-Affirming Hormone Therapy.
    Dix C, Moloney M, Tran HA, McFadyen JD.
    Thromb Haemost; 2024 May 18; 124(5):387-398. PubMed ID: 37816389
    [Abstract] [Full Text] [Related]

  • 16. SERUM HORMONE CONCENTRATIONS IN TRANSGENDER INDIVIDUALS RECEIVING GENDER-AFFIRMING HORMONE THERAPY: A LONGITUDINAL RETROSPECTIVE COHORT STUDY.
    Chantrapanichkul P, Stevenson MO, Suppakitjanusant P, Goodman M, Tangpricha V.
    Endocr Pract; 2021 Jan 18; 27(1):27-33. PubMed ID: 33471729
    [Abstract] [Full Text] [Related]

  • 17. Gender affirming hormonal treatment in Danish transgender persons: A nationwide register-based study.
    Glintborg D, Rubin KH, Kristensen SB, Lidegaard Ø, T'Sjoen G, Hilden M, Andersen MS.
    Andrology; 2022 Jul 18; 10(5):885-893. PubMed ID: 35366390
    [Abstract] [Full Text] [Related]

  • 18. Does Gender-Affirming Hormonal Treatment Affect 30-Year Cardiovascular Risk in Transgender Persons? A Two-Year Prospective European Study (ENIGI).
    Cocchetti C, Castellini G, Iacuaniello D, Romani A, Maggi M, Vignozzi L, Schreiner T, den Heijer M, T'Sjoen G, Fisher AD.
    J Sex Med; 2021 Apr 18; 18(4):821-829. PubMed ID: 33745831
    [Abstract] [Full Text] [Related]

  • 19. Gender-Affirming Hormone Use in Transgender Individuals: Impact on Behavioral Health and Cognition.
    Nguyen HB, Chavez AM, Lipner E, Hantsoo L, Kornfield SL, Davies RD, Epperson CN.
    Curr Psychiatry Rep; 2018 Oct 11; 20(12):110. PubMed ID: 30306351
    [Abstract] [Full Text] [Related]

  • 20. Gender-Affirming Hormone Treatment and Metabolic Syndrome Among Transgender Veterans.
    Hashemi L, Marijic Buljubasic A, Budoff MJ, Copeland LA, Jackson NJ, Jasuja GK, Gornbein J, Reue K.
    JAMA Netw Open; 2024 Jul 01; 7(7):e2419696. PubMed ID: 38954413
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.